Binding of human papillomavirus 16 E6 to p53 and E6AP is impaired by monoclonal antibodies directed against the second zinc-binding domain of E6

References

1. Banks L., Matlashewski G., Crawford L. 1986; Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression. Eur J Biochem 159:529–534 [CrossRef]
   [Google Scholar]
2. Bedell M. A., Jones K. H., Laimins L. A. 1987; The E6-E7 region of human papillomavirus type 18 is sufficient for transformation of NIH 3T3 and rat-1 cells. J Virol 61:3635–3640
   [Google Scholar]
3. Choulier L., Orfanoudakis G., Robinson P., Laune D., Ben Khalifa M., Granier C., Weiss E., Altschuh D. 2002; Comparative properties of two peptide–antibody interactions as deduced from epitope delineation. J Immunol Methods 259:77–86 [CrossRef]
   [Google Scholar]
4. Clifford G. M., Smith J. S., Plummer M., Munoz N., Franceschi S. 2003; Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 88:63–73 [CrossRef]
   [Google Scholar]
5. Cooper B., Schneider S., Bohl J., Jiang Y., Beaudet A., Vande Pol S. 2003; Requirement of E6AP and the features of human papillomavirus E6 necessary to support degradation of p53. Virology 306:87–99 [CrossRef]
   [Google Scholar]
6. Crook T., Tidy J. A., Vousden K. H. 1991; Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell 67:547–556 [CrossRef]
   [Google Scholar]
7. Deryckere F., Burgert H. G. 1996; Early region 3 of adenovirus type 19 (subgroup D) encodes an HLA-binding protein distinct from that of subgroups B and C. J Virol 70:2832–2841
   [Google Scholar]
8. Foster S. A., Demers G. W., Etscheid B. G., Galloway D. A. 1994; The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest. J Virol 68:5698–5705
   [Google Scholar]
9. Gewin L., Galloway D. A. 2001; E box-dependent activation of telomerase by human papillomavirus type 16 E6 does not require induction of c- myc . J Virol 75:7198–7201 [CrossRef]
   [Google Scholar]
10. Giovane C., Trav G., Briones A., Lutz Y., Wasylyk B., Weiss E. 1999; Targetting of the N-terminal domain of the human papillomavirus type 16 E6 oncoprotein with monomeric ScFvs blocks the E6-mediated degradation of cellular p53. J Mol Recognit 12:141–152 [CrossRef]
    [Google Scholar]
11. Green S., Isseman I., Sheer E. 1988; A versatile in vivo and in vitro eukaryotic expression vector for protein engineering. Nucleic Acids Res 16:369 [CrossRef]
    [Google Scholar]
12. Grm H. S., Banks L. 2004; Degradation of hDlg and MAGIs by human papillomavirus E6 is E6-AP-independent. J Gen Virol 85:2815–2819 [CrossRef]
    [Google Scholar]
13. Herber R., Liem A., Pitot H., Lambert P. F. 1996; Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene. J Virol 70:1873–1881
    [Google Scholar]
14. Huibregtse J. M., Scheffner M., Howley P. M. 1993; Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Mol Cell Biol 13:4918–4927
    [Google Scholar]
15. Li X., Coffino P. 1996; High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation. J Virol 70:4509–4516
    [Google Scholar]
16. Liu Y., Chen J. J., Gao Q., Dalal S., Hong Y., Mansur C. P., Band V., Androphy E. J. 1999; Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells. J Virol 73:7297–7307
    [Google Scholar]
17. Mantovani F., Banks L. 2001; The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 20:7874–7887 [CrossRef]
    [Google Scholar]
18. Masson M., Hindelang C., Sibler A. P., Schwalbach G., Trave G., Weiss E. 2003; Preferential nuclear localization of the human papillomavirus type 16 E6 oncoprotein in cervical carcinoma cells. J Gen Virol 84:2099–2104 [CrossRef]
    [Google Scholar]
19. Matlashewski G., Schneider J., Banks L., Jones N., Murray A., Crawford L. 1987; Human papillomavirus type 16 DNA cooperates with activated ras in transforming primary cells. EMBO J 6:1741–1746
    [Google Scholar]
20. Pim D., Banks L. 1999; HPV-18 E6*I protein modulates the E6-directed degradation of p53 by binding to full-length HPV-18 E6. Oncogene 18:7403–7408 [CrossRef]
    [Google Scholar]
21. Pim D., Thomas M., Javier R., Gardiol D., Banks L. 2000; HPV E6 targeted degradation of the discs large protein: evidence for the involvement of a novel ubiquitin ligase. Oncogene 19:719–725 [CrossRef]
    [Google Scholar]
22. Ristriani T., Nomine Y., Masson M., Weiss E., Trave G. 2001; Specific recognition of four-way DNA junctions by the C-terminal zinc-binding domain of HPV oncoprotein E6. J Mol Biol 305:729–739 [CrossRef]
    [Google Scholar]
23. Scheffner M., Werness B. A., Huibregtse J. M., Levine A. J., Howley P. M. 1990; The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129–1136 [CrossRef]
    [Google Scholar]
24. Schwalbach G., Sibler A. P., Choulier L., Deryckere F., Weiss E. 2000; Production of fluorescent single-chain antibody fragments in Escherichia coli . Protein Expr Purif 18:121–132 [CrossRef]
    [Google Scholar]
25. Sibler A. P., Nordhammer A., Masson M., Martineau P., Trave G., Weiss E. 2003; Nucleocytoplasmic shuttling of antigen in mammalian cells conferred by a soluble versus insoluble single-chain antibody fragment equipped with import/export signals. Exp Cell Res 286:276–287 [CrossRef]
    [Google Scholar]
26. Song S., Pitot H. C., Lambert P. F. 1999; The human papillomavirus type 16 E6 gene alone is sufficient to induce carcinomas in transgenic animals. J Virol 73:5887–5893
    [Google Scholar]
27. Vousden K. H., Doniger J., DiPaolo J. A., Lowy D. R. 1988; The E7 open reading frame of human papillomavirus type 16 encodes a transforming gene. Oncogene Res 3:167–175
    [Google Scholar]
28. Walboomers J. M., Jacobs M. V., Manos M. M. 7 other authors 1999; Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12–19 [CrossRef]
    [Google Scholar]
29. Watanabe S., Kanda T., Yoshiike K. 1989; Human papillomavirus type 16 transformation of primary human embryonic fibroblasts requires expression of open reading frames E6 and E7. J Virol 63:965–969
    [Google Scholar]